#United States #Boca Raton #Radiation Oncology #Empyrean Medical #Artemis™ 320

A Milestone for Empyrean Medical Systems

Empyrean Medical Systems, Inc., a leading innovator in radiation oncology, has achieved a substantial milestone with the installation of the Artemis™ 320 system at a prominent cancer research center in the United States. This state-of-the-art X-ray irradiator is meticulously designed for preclinical radiation research in various fields, including oncology, immunology, and bio-radiology.

The Artemis™ 320 represents a significant leap forward in the capabilities of radiation oncology equipment. Engineered with integrated standardized dosimetry, the system ensures precise and reproducible radiation delivery, thereby supporting the rigorous demands of scientific research. As this system is fully equipped with advanced features such as augmented-reality beam positioning and automated logging, it streamlines the research process for scientists working in preclinical environments.

Christopher J. Bakkenist, Ph.D., who holds the Chair in Radiation Oncology Research at the research center, expressed enthusiasm regarding the Artemis™ 320, stating, "We are very excited to take delivery of the new machine that will allow us to deliver X-rays in our facility with sufficient energy for bone marrow transplantation. This machine meets an unmet need in the market, which is enormous."

Another noteworthy feature of the Artemis™ 320 is its alignment with the goals of the Department of Homeland Security's Cesium Replacement Program (CIRP), making it the first system to do so while providing accurate dosimetry suitable for research purposes. This innovation addresses a significant demand in the field of radiation biology, enabling academic institutions and cancer centers to pursue critical research in hematologic diseases and cancer treatments with unprecedented accuracy and consistency.

"The launch of the Artemis™ 320 is a significant milestone for Empyrean. We are thrilled to provide research institutions with this next-generation X-ray irradiator, which offers precision, reliability, and enhanced workflow while maintaining the highest research impact," remarked Pavlina Frolik, Vice President of Sales & Marketing at Empyrean.

Currently, Empyrean Medical Systems is in discussions with various academic centers to promote the Artemis™ 320 as the new standard in preclinical radiation research. Additionally, the system is available for purchase through the CIRP program as well as other institutional funding initiatives. This innovative leap is not merely a technological advancement but a necessary evolution in the realm of medical research.

With the Artemis™ 320, Empyrean aims to redefine the landscape of radiation oncology research by simplifying workflows and ensuring transparent, standardized dosimetry. This pivotal development stands to elevate the quality and reliability of preclinical studies and further propel advancements in cancer research and treatment methodologies. As the Artemis™ 320 sets a new benchmark in the industry, it promises to enhance the productivity and effectiveness of research teams, ultimately leading to breakthroughs in oncology and related fields.

For more information regarding the Artemis™ 320 and how it can benefit your research initiatives, please contact Empyrean Medical Systems, Inc. at their Boca Raton office. Together, we can explore the future of radiation oncology research and the significant impact it holds for medical science and patient care.

Empyrean Medical Systems, Inc.
3010 N Military Trail #220, Boca Raton, FL 33431
Contact: (561) 931-2086
Email: [email protected]
Website: www.empyreanmed.com